disease with X-linked dominant inheritance. [1] RTT is one of the most frequent causes of mental retardation in females and affects 1/15,000 females worldwide, [2] nearly 1/10000 girls by 12 years of age. Other genetic causes of X-linked mental retardation are mostly inherited as recessive diseases.
Inheritance of RTT and the evolution of the disease in patients is very characteristic. The classical form of the disease is found almost exclusively in females. However males with the classical phenotype of RTT have been reported who were carriers of X-chromosome numerical anomalies. [3] In the classical form, the baby is apparently normal at birth, with normal height, weight, and head circumference. Development is apparently normal till 6-18 months of age, with developmental milestones like sitting, walking, or talking achieved normally. [4] This is then followed by a phase of developmental arrest and regression. Surprisingly, the fi rst symptoms are reported mostly between 6-12 months of age. It has been shown that affected infants are not totally normal in fi rst 6 months of development. [4] The main pathology in the brain is neuronal development arrest. In fact, the average weight of the brain in an RTT patient is equal to that of an infant of 12 months of age. [5] About 80% of RTT have a mutation in transcriptional silencer MeCP2 gene. Other genes, like CDKL5 and NTNG1, have also been implicated in a limited number of cases of RTT.
Case Report
The proposita was the fi rst child of healthy, unrelated parents. The family history was unremarkable. The mother and father were 21 and 27 years old, respectively, at the time of the infant's birth. Pregnancy was uneventful and prenatal ultrasonography had shown no anomaly.
At 39 weeks' gestation, a baby girl was delivered; the birth weight was 3000 gm, length 52 cm, and OFC (occipitofrontal circumference) 34 cm.
Psychomotor development was normal till 7 months of age, when she lost the ability to hold objects in her hand.
However, her parents also mentioned diffi culties in breast feeding and nocturnal rhythm quite early in infancy.
Since 2 years of age she had had tonic-clonic epilepsy, which was worse following awakening from sleep. The seizures could be controlled with carbamazepine. 
Materials and Methods
Total genomic DNA was extracted from peripheral blood leukocytes by standard procedures. We amplifi ed three coding exons of MeCP2 gene by polymerase chain reaction (PCR), using Taq DNA polymerase (Roche Diagnostics). The six primers used to amplify the three exons are described elsewhere. [6] The PCR conditions included an initial denaturation at 94°C for 2 min, followed by 30 cycles of denaturation at 94°C for 20 s, annealing at 59°C for 20 s, and extension at 72°C for 1 min, with a fi nal extension step of 72°C for 10 min. We examined the purity of the PCR products on 12% polyacrylamide gel and sequenced them directly using dye-terminator chemistry on an automated sequencer (ABI Prism 310, Perkin Elmer, Applied Biosystems).
Results and Discussion
We found a 502C>T nonsense mutation in exon 4 of no apparent mutation has been found in exon 2.
We report the fi rst case of MeCP2 mutation in Iran in a girl with classical RTT. The mother of the patient was pregnant when she sought our help for her ongoing pregnancy. Genetic analysis in the parents showed no genetic alteration in wild-type MeCP2. Sequence analysis in CVS DNA showed no alteration of sequence.
Since in 1% of cases the pathogenic mutation can be familial, genetic analysis of the parents is recommended. If the mutation is found in the mother, PND must be advised in all future pregnancies. If genetic analysis of the mother shows wild-type MeCP2 sequence, the mutation is de novo.
However, as the risk of germinal mosaicism exists and some familial cases of RTT (without apparent MeCP2 mutation in the parents) are reported in the literature, [8] the possibility of PND, even in the absence of genomic mutation in parents, must be discussed with the couple. MeCP2 mutations might account for 2% of males with unexplained mental retardation. [9] In females with autism, atypical Angleman syndrome, and males or females with unexplained mental retardation, a mutation in MeCP2 can be implicated. Even if clinical and genetic diagnosis in these families is diffi cult, the positive impact of knowing that there is a genetic cause for the MR would be undeniable for parents and other members of the family.
Mutations in
Recently, mutations of CDKL5 and NTNG1 have been found in phenotypes which overlap signifi cantly with RTT. [10] As little is known about the incidence and phenotypic variation of these two genes, it is diffi cult to propose genetic analysis of these two genes, at least at the diagnostic level. Further genetic and epidemiologic research is needed to delineate recommendations on this issue.
